564 studies found for:
Open Studies | ovarian cancer
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Interactive Educational Website for Women With Ovarian Cancer & Caregivers
|
||||
| 2 | Recruiting |
Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
|
||||
| 3 | Recruiting |
Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
|
||||
| 4 | Not yet recruiting |
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
|
||||
| 5 | Recruiting |
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
|
||||
| 6 | Recruiting |
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
|
||||
| 7 | Recruiting |
AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
|
||||
| 8 | Recruiting |
M. D. Anderson Symptom Inventory - Ovarian Cancer
|
||||
| 9 | Recruiting |
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
|
||||
| 10 | Unknown † |
A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
|
||||
| 11 | Recruiting |
Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
|
||||
| 12 | Recruiting |
Trial of Adjuvant FANG™ Vaccine for High Risk Stage III/IV Ovarian Cancer
|
||||
| 13 | Recruiting |
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
|
||||
| 14 | Recruiting |
Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer
|
||||
| 15 | Recruiting |
18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
|
||||
| 16 | Recruiting |
Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer
|
||||
| 17 | Recruiting |
Sentinel Node in Ovarian Cancer
|
||||
| 18 | Unknown † |
Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer
|
||||
| 19 | Recruiting |
Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
|
||||
| 20 | Recruiting |
A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
|
† Indicates status has not been verified in more than two years
